Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 70

Results For "ISA"

1072 News Found

AstraZeneca’s new R&D Centre and Alexion HQ in Cambridge, Massachusetts
News | May 01, 2022

AstraZeneca’s new R&D Centre and Alexion HQ in Cambridge, Massachusetts

Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub


ASPIRE 2022 Congress: Recognising the 'tip of the iceberg' in the complex and chronic effects of endometriosis
Public Health | May 01, 2022

ASPIRE 2022 Congress: Recognising the 'tip of the iceberg' in the complex and chronic effects of endometriosis

It affects up to 10 per cent of women of reproductive age around the world


Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar
News | April 29, 2022

Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar

The plant is expected to start commercial operations from Q4FY24


SPARSH Hospital introduces high precision Surgical Imaging and Navigation system
Hospitals | April 27, 2022

SPARSH Hospital introduces high precision Surgical Imaging and Navigation system

The StealthStation S8 and O-arm Surgical Navigation solution make a complex surgery seem more routine and free of any errors


Syngene full-year revenue from operations up 19% to Rs. 2604 crore
News | April 27, 2022

Syngene full-year revenue from operations up 19% to Rs. 2604 crore

Revenue from operations up 15% to Rs. 758 crore in fourth quarter


Roche and Fitterfly co-create 90-day diabetes programme
Startup | April 26, 2022

Roche and Fitterfly co-create 90-day diabetes programme

Designed to give instant insights on blood sugar, in-depth nutrition and wellness, this programme provides fitness assessments, personalisation and reports for doctors


Drugs Controller clears Covaxin, Corbevax and ZyCov-D for kids
News | April 26, 2022

Drugs Controller clears Covaxin, Corbevax and ZyCov-D for kids

The approval by the DCGI comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO)


Corbevax gets DCGI nod for Emergency Use in 5-12 years
Drug Approval | April 26, 2022

Corbevax gets DCGI nod for Emergency Use in 5-12 years

The approval comes soon after Corbevax was given the nod for 12-15-year group


DCGI grants Covaxin Emergency Use Approval for children 6-12 years
Drug Approval | April 26, 2022

DCGI grants Covaxin Emergency Use Approval for children 6-12 years

Covaxin was earlier approved for children 12-18 years of age


ZyCoV-D two-dose vaccine receives Emergency Use Approval from DCGI
Drug Approval | April 26, 2022

ZyCoV-D two-dose vaccine receives Emergency Use Approval from DCGI

The two-dose regimen for ZyCoV-D was tested in 3100 healthy volunteers more than 12 years of age